Paper39799339
Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives.
Skarne N and 5 others. Acta Neuropathol Commun, 2025. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives. Papers, record 39799339. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39799339
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioblastoma | Major topic |
| Organoids | Major topic |
| Precision Medicine | Major topic |
| Brain Neoplasms | Major topic |
| Humans | |
| Animals | |
| Tumor Microenvironment |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GA59729 | the Medical Research Future Fund (MRFF) Rapid Applied Research Translation Program, Centre for Personalised Analysis of Cancers (CPAC) | PubMed | ||
| 2021/GNT2013180 and 2023/GNT2030541 | NHMRC | PubMed | ||
| 2023943 | the Medical Research Future Fund (MRFF) Australian Brain Cancer Infrastructure Grant | PubMed |
Source PubMed
References114
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26136784 | EGFR Amplification and Glioblastoma Stem-Like Cells. | Stem Cells Int | 2015 | https://conductscience.org/library/papers/26136784 | PubMed |
| 2 | 36634170 | FDA no longer has to require animal testing for new drugs. | Science | 2023 | https://conductscience.org/library/papers/36634170 | PubMed |
| 3 | 28670477 | Ex vivo tumor culture systems for functional drug testing and therapy response prediction. | Future Sci OA | 2017 | https://conductscience.org/library/papers/28670477 | PubMed |
| 4 | 36823172 | Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas. | Nat Commun | 2023 | https://conductscience.org/library/papers/36823172 | PubMed |
| 5 | 26644564 | Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26644564 | PubMed |
| 6 | 32793885 | Multiomics profiling of paired primary and recurrent glioblastoma patient tissues. | Neurooncol Adv | 2020 | https://conductscience.org/library/papers/32793885 | PubMed |
| 7 | 19011762 | Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model. | J Neurooncol | 2009 | https://conductscience.org/library/papers/19011762 | PubMed |
| 8 | 25305336 | Lessons from patient-derived xenografts for better in vitro modeling of human cancer. | Adv Drug Deliv Rev | 2014 | https://conductscience.org/library/papers/25305336 | PubMed |
| 9 | 38130902 | Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity. | Neurooncol Adv | 2023 | https://conductscience.org/library/papers/38130902 | PubMed |
| 10 | 33014387 | Introduction to immunotherapy for brain tumor patients: challenges and future perspectives. | Neurooncol Pract | 2020 | https://conductscience.org/library/papers/33014387 | PubMed |
| 11 | 36690742 | Screening cell-cell communication in spatial transcriptomics via collective optimal transport. | Nat Methods | 2023 | https://conductscience.org/library/papers/36690742 | PubMed |
| 12 | 25053711 | Epidemiologic and molecular prognostic review of glioblastoma. | Cancer Epidemiol Biomarkers Prev | 2014 | https://conductscience.org/library/papers/25053711 | PubMed |
| 13 | 30191323 | Engineered 3D tumour model for study of glioblastoma aggressiveness and drug evaluation on a detachably assembled microfluidic device. | Biomed Microdevices | 2018 | https://conductscience.org/library/papers/30191323 | PubMed |
| 14 | 33173111 | Patient-derived ovarian cancer explants: preserved viability and histopathological features in long-term agitation-based cultures. | Sci Rep | 2020 | https://conductscience.org/library/papers/33173111 | PubMed |
| 15 | 32297954 | Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics. | Neuro Oncol | 2020 | https://conductscience.org/library/papers/32297954 | PubMed |
| 16 | 26427041 | Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics. | Oncotarget | 2015 | https://conductscience.org/library/papers/26427041 | PubMed |
| 17 | 33554067 | How well do brain organoids capture your brain? | iScience | 2021 | https://conductscience.org/library/papers/33554067 | PubMed |
| 18 | 37190047 | Evaluation of 3D Human Intestinal Organoids as a Platform for EV-A71 Antiviral Drug Discovery. | Cells | 2023 | https://conductscience.org/library/papers/37190047 | PubMed |
| 19 | 26896279 | A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. | Cancer Res | 2016 | https://conductscience.org/library/papers/26896279 | PubMed |
| 20 | 35858406 | Tropism of SARS-CoV-2 for human cortical astrocytes. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/35858406 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42649915 | Construction Strategies, Microenvironmental Modelling and Precision-Therapy Applications of Glioma Organoid Models. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649915 | PubMed |
| 42503464 | From patient to tumor organoid: Culture protocol choice controls glioblastoma tumor architecture and identity. | Brain Pathol | 2026 | https://conductscience.org/library/papers/42503464 | PubMed |
| 42239104 | Cryopreservation of brain organoids - a tool for on-demand organoid banking. | bioRxiv | 2026 | https://conductscience.org/library/papers/42239104 | PubMed |
| 42116568 | Flash Assembloids: A Rapid Biofabrication of a Platform for Modeling Early Glioblastoma Invasion at the Glioblastoma-Brain Organoid Interfaces. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42116568 | PubMed |
| 42068033 | Integrated 2D-3D Proteomic Profiling Identifies MLK4 as a Microenvironment-Responsive Regulator of Chemotherapeutic Resistance in Human Glioblastoma Cells. | Biol Cell | 2026 | https://conductscience.org/library/papers/42068033 | PubMed |
| 41899611 | Ultrasound-Based Therapies in Primary Central Nervous System Tumors. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41899611 | PubMed |
| 41749921 | Advancing the Study of Glioblastoma Through 3D Tumor Models. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41749921 | PubMed |
| 41357191 | Mapping TAM-tumor crosstalk in glioma via ligand-receptor multi-omics: mechanisms of immune evasion. | Front Immunol | 2025 | https://conductscience.org/library/papers/41357191 | PubMed |
| 41300282 | Modeling Glioblastoma for Translation: Strengths and Pitfalls of Preclinical Studies. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/41300282 | PubMed |
| 41270976 | Informing development of brain cancer therapies within "preclinical trials" using ex vivo patient tumors. | Adv Drug Deliv Rev | 2026 | https://conductscience.org/library/papers/41270976 | PubMed |
| 40940872 | Choice of Animal Models to Investigate Cell Migration and Invasion in Glioblastoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40940872 | PubMed |
| 40140938 | From gut to liver: organoids as platforms for next-generation toxicology assessment vehicles for xenobiotics. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40140938 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39799339
GET https://conductscience.org/api/papers/v1/39799339/references?page=2